NATH BIOGENES (INDIA)
Quarterly Results Analysis [Jun2025]
NATH BIOGENES (INDIA) Quarterly Results
Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 Audited |
Sep2024 Audited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹284 Cr | ₹52 Cr | ₹37 Cr | ₹32 Cr | ₹244 Cr | ₹43 Cr | ₹32 Cr | ₹23 Cr |
Expenses | ₹245 Cr | ₹52 Cr | ₹29 Cr | ₹27 Cr | ₹207 Cr | ₹39 Cr | ₹26 Cr | ₹18 Cr |
Operating Income | ₹38 Cr | ₹0 Cr | ₹8 Cr | ₹5 Cr | ₹37 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr |
Other Income | ₹2 Cr | ₹4 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹3 Cr | ₹1 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹36 Cr | ₹2 Cr | ₹4 Cr | ₹1 Cr | ₹34 Cr | ₹2 Cr | ₹5 Cr | ₹2 Cr |
Profit After Tax | ₹35 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹33 Cr | ₹2 Cr | ₹4 Cr | ₹2 Cr |
EPS | ₹19.62 | ₹0.78 | ₹1.39 | ₹0.59 | ₹17.55 | ₹1.38 | ₹2.01 | ₹0.80 |
Industry Peers & Returns | 1W | 1M | 1Y |
NATH BIOGENES (INDIA) | -4.1% | -23% | -24% |
BOMBAY BURMAH TRADING CORPORATION | -3% | -6.8% | -12.5% |
KAVERI SEED COMPANY | -2.1% | -8.1% | 4.2% |
VENKYS (INDIA) | 0.5% | -5.7% | -32% |
BOMBAY SUPER HYBRID SEEDS | -2.3% | -4.4% | -29.6% |
INDO US BIOTECH | -3.4% | 8% | -21.2% |
MANGALAM GLOBAL ENTERPRISE | -3.9% | -2.2% | NA |
HARRISONS MALAYALAM | 4.7% | 0.8% | -7% |
TIERRA AGROTECH | 6.7% | 2.4% | -35.7% |
NATH BIOGENES (INDIA) Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 445.91 % |
Y-o-Y | 16.33 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹284 Cr | 445.91 | |
Mar2025 | ₹52 Cr | 40.94 | |
Dec2024 | ₹37 Cr | 14.54 | |
Sep2024 | ₹32 Cr | -86.80 | |
Jun2024 | ₹244 Cr | 466.65 | |
Mar2024 | ₹43 Cr | 35.60 | |
Dec2023 | ₹32 Cr | 40.63 | |
Sep2023 | ₹23 Cr | - |
NATH BIOGENES (INDIA) Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 9,169.73 % |
Y-o-Y | 4.79 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹38 Cr | 9,169.73 | |
Mar2025 | ₹0 Cr | -94.86 | |
Dec2024 | ₹8 Cr | 67.01 | |
Sep2024 | ₹5 Cr | -86.83 | |
Jun2024 | ₹37 Cr | 830.12 | |
Mar2024 | ₹4 Cr | -30.43 | |
Dec2023 | ₹6 Cr | 13.35 | |
Sep2023 | ₹5 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 1,607.59 % |
Y-o-Y | -9.95 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | 13.49% | 1,607.59 | |
Mar2025 | 0.79% | -96.38 | |
Dec2024 | 21.8% | 45.82 | |
Sep2024 | 14.95% | -0.20 | |
Jun2024 | 14.98% | 64.07 | |
Mar2024 | 9.13% | -48.68 | |
Dec2023 | 17.79% | -19.39 | |
Sep2023 | 22.07% | - |
NATH BIOGENES (INDIA) Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 3,646.49 % |
Y-o-Y | 5.59 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹35 Cr | 3,646.49 | |
Mar2025 | ₹1 Cr | -64.54 | |
Dec2024 | ₹3 Cr | 137.97 | |
Sep2024 | ₹1 Cr | -96.66 | |
Jun2024 | ₹33 Cr | 1,897.25 | |
Mar2024 | ₹2 Cr | -56.27 | |
Dec2023 | ₹4 Cr | 154.43 | |
Sep2023 | ₹2 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 585.64 % |
Y-o-Y | -9.28 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 12.41 % | 585.64 | |
Mar2025 | 1.81 % | -74.83 | |
Dec2024 | 7.19 % | 107.80 | |
Sep2024 | 3.46 % | -74.71 | |
Jun2024 | 13.68 % | 252.58 | |
Mar2024 | 3.88 % | -67.75 | |
Dec2023 | 12.03 % | 80.90 | |
Sep2023 | 6.65 % | - |
NATH BIOGENES (INDIA) Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 2,415.38 % |
Y-o-Y | 11.79 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹19.62 | 2,415.38 | |
Mar2025 | ₹0.78 | -43.88 | |
Dec2024 | ₹1.39 | 135.59 | |
Sep2024 | ₹0.59 | -96.64 | |
Jun2024 | ₹17.55 | 1,171.74 | |
Mar2024 | ₹1.38 | -31.34 | |
Dec2023 | ₹2.01 | 151.25 | |
Sep2023 | ₹0.8 | - |
You may also like the below Video Courses
BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
BOMBAY SUPER HYBRID SEEDS LTD vs INDO US BIOTECH LTD vs MANGALAM GLOBAL ENTERPRISE LTD